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OBJECTIVE—Previous ﬁndings demonstrate that enhanced
expression of the forkhead transcription factor Foxc2 in adipose
tissue leads to a lean and insulin-sensitive phenotype. These
ﬁndings prompted us to further investigate the role of Foxc2 in
the regulation of genes of fundamental importance for metabo-
lism and mitochondrial function.
RESEARCH DESIGN AND METHODS—The effects of Foxc2
on expression of genes involved in mitochondriogenesis and
mitochondrial function were assessed by quantitative real-time
PCR. The potential of a direct transcriptional regulation of
regulated genes was tested in promoter assays, and mitochon-
drial morphology was investigated by electron microscopy.
Mitochondrial function was tested by measuring oxygen con-
sumption and extracellular acidiﬁcation rates as well as palmitate
oxidation.
RESULTS—Enhanced expression of FOXC2 in adipocytes or in
cells with no endogenous Foxc2 expression induces mitochon-
driogenesis and an elongated mitochondrial morphology. To-
gether with increased aerobic metabolic capacity, increased
palmitate oxidation, and upregulation of genes encoding re-
spiratory complexes and of brown fat-related genes, Foxc2 also
speciﬁcally induces mitochondrial fusion genes in adipocytes.
Among tested forkhead genes, Foxc2 is unique in its ability to
trans-activate the nuclear-encoded mitochondrial transcription
factor A (mtTFA/Tfam) gene—a master regulator of mitochon-
drial biogenesis. In human adipose tissue the expression levels
of mtTFA/Tfam and of fusion genes also correlate with that of
Foxc2.
CONCLUSIONS—We previously showed that a high-calorie diet
and insulin induce Foxc2 in adipocytes; the current ﬁndings
identify a previously unknown role for Foxc2 as an important
metabo-regulator of mitochondrial morphology and metabolism.
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itochondrial number and activity are essential
for many cellular functions such as ATP
production through oxidative phosphory-
lation and biosynthesis of amino acids and
lipids (1). Peroxisome proliferator–activated receptor g
coactivator-1 a (PGC1a) lies upstream of the nuclear-
encoded mitochondrial transcription factor A (mtTFA/
Tfam) and serves as a nutrient-sensing system that
increases mitochondrial biogenesis (2). In the muscle
compartment PGC1a-responsive genes linked to mito-
chondrial function are suppressed in humans with diabetes
(3). Several investigations point toward a direct or indirect
role for the mitochondria in metabolic disorders like in-
sulin resistance and type 2 diabetes (4–7). Much research
interest has focused on skeletal muscle since it accounts
for ;80% of insulin-mediated glucose uptake in healthy
humans. Of note, however, is the fact that the ablation of
the insulin receptor in skeletal muscle does not result in
overt diabetes or hyperinsulinemia (8). The adipose tissue
compartment compensates for this defect by increasing its
insulin-mediated glucose uptake approximately threefold
(8), demonstrating clearly the capacity and overall im-
portance of the metabolic interrelationships between adi-
pose and muscle tissues. The capacity of adult humans to
recruit mitochondria dense, energy spending brown adi-
pose tissue (BAT) has been known for some time, as
demonstrated by individuals with catecholamine-secreting
tumors like phaeochromocytomas and paragangliomas; in
such conditions distinct BAT depots develop (9). Lately
active BAT has also been discovered in healthy adult
humans (10–12), and the activation of this tissue or in-
duction of BAT-like white adipose tissue (WAT) in humans
is a highly interesting and relevant target for an antiobesity
remedy.
With this in mind, and based on previous ﬁndings dem-
onstrating that enhanced expression of the transcription
factor forkhead box c2 (Foxc2) in adipose tissue leads to
a lean and insulin-sensitive phenotype, which is also
characterized by an enlarged BAT compartment (13), we
set out to study Foxc2 regulation and effects on metabo-
lism. We found that Foxc2 appears to induce mitochon-
driogenesis through activation of the mtTFA/Tfam
promoter. Furthermore, Foxc2 induces mitochondrial fu-
sion via activation of mitofusin 1 (Mfn1), mitofusin 2
(Mfn2), and optic atrophy 1 homolog (Opa1), when it is
overexpressed in adipocytes and when expressed ectopi-
cally. In human adipose tissue we also found a positive
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ORIGINAL ARTICLEcorrelation between Foxc2 expression level and that of
mtTFA/Tfam and Mfn1, Mfn2, and OPA1, supporting the
view that this type of regulation extends to humans. This is
interesting since there is growing evidence that reduction
in mitochondrial fusion is an important etiological factor in
development of obesity and insulin resistance (1,14,15).
Based on previous ﬁndings demonstrating that Foxc2 is
upregulated in response to insulin (16) and high-caloric
diet (13) and on results presented herein, we propose that
Foxc2 is crucial in a metabolically regulated gene circuit,
allowing the adipocyte to adapt to alterations in systemic
substrate availability.
RESEARCH DESIGN AND METHODS
Cell culture and transfections. 3T3-L1 cells and human embryonic kidney
293 (HEK293) cells (American Type Culture Collection) were cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM), 4.5 g/L glucose, 10% heat-
inactivated FBS (Invitrogen), 100 U/mL penicillin, and 100 mg/mL streptomy-
cin. Transfections of 3T3-L1 cells were carried out in 24-well plates using
FUGENE 6 (Roche) according to the manufacturer’s recommendations. In
brief, reporter vectors were cotransfected with 3 ng pRL-SV40 Renilla
(Promega) and an increasing amount of expression vector. Empty expression
vector was added to get a ﬁnal DNA amount of 1 mg per transfection. The
transfection mixes were added to ;95% conﬂuent cells, and after 17 h of
culture in DMEM containing 10% FBS, differentiation was induced by sup-
plementing the media to 5 mg/mL insulin (Sigma), 10 mmol/L dexamethasone
(Sigma), and 0.5 mmol/L 3-isobutyl-1-methylxanthine (Sigma). After two days
the media were replaced by DMEM containing 10% FBS and 5 mg/mL insulin.
The following day cells were lysed in passive lysis buffer (Promega), and the
luciferase activities were measured on a TD 20/20 luminometer (Turner
Designs) using the Dual-Luciferase Reporter Assay system (Promega). The
luciferase activity was normalized to the Renilla luciferase activity. The
FOXC2 expression plasmid was made up by cloning FOXC2 (nt 1192–3289,
GenBank: Y08223) into the pCB6
+ vector. Other expression vectors used were:
pEVRF0-FOXF2, pcDNA3.1/GS-FOXI1, and pCDNA3-FLAG-FOXO1. For the
promoter studies, PCR ampliﬁed promoter regions of Mfn1 (nt 89726–92244
GenBank: AC130281, 2.5 kb region upstream of ﬁrst exon), Mfn2 (nt 114316–
117735, GenBank: AL607066, 3.2 kb region upstream of ﬁrst exon), and mtTFA
(nt 137612–140034 GenBank: AC023170, 2.3 kb region upstream of ﬁrst exon)
were ligated into the pGL3-Basic (Promega). HEK293 cells overexpressing
FOXC2 in a doxycycline-inducible way were created by introducing
a pTRE2hyg vector (Clontech) harboring a sequence encoding FOXC2 with
a COOH-terminal His-tag into 293 pTet-On cells (Clontech) and selecting for
stable transfectant clones according to the manufacturers recommendations.
HEK293-FOXC2-His Tet-On cells were grown in DMEM containing 4.5 g/L
glucose, 10% Tet System Approved FBS (Clontech), 100 U/mL penicillin, and
100 mg/mL streptomycin. FOXC2-His expression was induced by supple-
menting the media with 2 mg/mL doxycycline (Clonetech). Mouse embryonic
ﬁbroblasts (MEFs) from wild-type (WT), FOXC2 transgenic (13), and Foxc2-
deﬁcient (17) embryos were isolated, grown, and differentiated into adipo-
cytes as previously published (18). Although Foxc2-deﬁcient mice die before
or around the time of birth, they survive to E12–14, thus long enough to allow
preparation of MEFs that lack Foxc2 expression.
FOXC2 adenovirus was constructed using the ViraPower Adenovirus Ex-
pression System (Invitrogen). Brieﬂy, virus was produced by transfecting
HEK293 cells with pAd/CMV/V5-DEST vector containing full-length human
FOXC2 cDNA and further ampliﬁed and titered before infecting adipocytes.
HumanpreadipocytesisolatedfromhealthydonorswithBMIunder25(ZenBio)
were seeded in 24-well plates and differentiated according to the manu-
facturers’ recommendations. After 10 days of differentiation, cells were
infected either by control adenovirus expressing ZS-green or by adenovirus
expressing FOXC2 (50 multiplicity of infection/cell). After infection (72 h),
total RNA was isolated using RNeasy Mini (Qiagen) and used for further
studies.
Animals and cold adaptation. Cold adaptation experiments were carried out
using two groups of 12-week-old C57Bl/6 mice each consisting of 10 animals
(ﬁve males and ﬁve females; ethical permission, 344/08, Ethical Committee of
Western Sweden). One group was kept at 4°C for 16 h, whereas the control
group was kept at 20°C. WAT and BAT were dissected, and total RNA was
isolated using Micro-to-Midi Total RNA Puriﬁcation System (Invitrogen)
according to manufacturer’s instructions. Mice were fed a standard chow diet
with 4% (wt/wt) fat content.
Reverse transcription and real-time PCR. Reverse transcription of 1 mg
total RNA was carried out using a ﬁrst strand cDNA synthesis kit for RT-PCR
(Roche). Real-time PCR was performed using TaqMan Fast Universal PCR
Master Mix and the 7900HT Fast Real-Time PCR System (Applied Biosystems).
Primer sequences are available on request. The TaqMan assays were chosen to
span an exon junction and therefore did not detect genomic DNA. For spec-
iﬁcity, selected samples were analyzed twice with and without reverse tran-
scriptase, and no ampliﬁcation was seen in samples in the absence of reverse
transcriptase.
Western blot analysis. Cell lysates were prepared using a lysis buffer
(50 mmol/L Tris-HCl [pH 8.0], 1% [vol/vol] Triton X-100, 0.5% [wt/vol] sodium
deoxycholate, 0.1% [wt/vol] SDS, and 150 mmol/L NaCl) containing protease
inhibitors (Complete, Roche). Equal protein amounts, as assessed by bicin-
choninic acid (BCA) Protein Assay (Pierce), were separated by SDS-PAGE and
blotted to a polyvinylidene ﬂuoride (PVDF) membrane (Immobilon-P, Milli-
pore). The membrane was blocked in PBS, 0.1% (vol/vol) Tween 20, and 5% (wt/
vol) milk powder, and FOXC2-His expression was determined using an anti-His
tag antibody (Abcam).
Electron microscopy. Cells were processed for electron microscopy, using
a double ﬁxation protocol with osmium and tannic acid (19). Samples were
dehydrated in graded ethanol series and embedded in epon 812 (Serva). After
48 h at 60°C to allow polymerization, ultra-thin sections (60 nm) were cut and
mounted on grids. Samples were examined on a LEO 912 OMEGA (Zeiss) at
120 kV accelerating voltage. Digital images were obtained by a side-mount
MegaView III TEM charge-coupled device (CCD) camera. Morphometric
analysis of mitochondria was performed with Volocity Quantitation 4.2
(Improvision), on digital images of equal magniﬁcation based on true cross-
sections of mitochondrial proﬁles.
Metabolic analyses. Undifferentiated MEFs were seeded (20,000 cells/well)
into 24-well Seahorse XF24 plates (28 mm
2 wells) precoated with 0.4% gelatin
(Invitrogen). MEFs were differentiated for 6 days, and O2 consumption rate
(OCR) and extracellular acidiﬁcation rate (ECAR) were determined in an
XF24 Extracellular Flux Analyzer (Seahorse Bioscience), as previously de-
scribed (20). The OCR values were obtained by measuring the ﬁrst 30 mmHg
drop in O2 partial pressure. ECAR values were measured as the rate of change
of pH over the duration of the measurement period, usually 2 min. To obtain
basal metabolic characteristics of cells, there were three measurement
cycles. To assess the effects of an uncoupler and an electron transport chain
inhibitor, p-triﬂuoromethoxy carbonyl cyanide phenylhydrazone (FCCP)
(1 mmol/L) or antimycin A (50 nmol/L) was injected into the wells, and three
more measurement cycles followed. Subsequent to metabolic analyses, MEFs
were trypsinized, and total cellular protein was determined using a BCA
assay.
Palmitate oxidation. Free fatty acid oxidation was assessed according to
Rune et al. (21), by exposing MEF adipocytes to [
3H]palmitic acid and mea-
suring the tritiated water produced. Adipocytes, cultured in 24-well plates,
were washed twice with PBS and exposed to 0.25 mL of DMEM, 1 g/L glucose
supplemented with 0.2% fatty acid free BSA (Sigma-Aldrich, A8806), and 0.125
mCi palmitic acid [9–10(n)-
3H] (5 mCi/mL, ﬁnal speciﬁc activity 47.7 Ci/mmol;
PerkinElmer), with or without 100 nmol/L insulin or 1 mmol/L AICAR (Sigma-
Aldrich) for 5.5 h. Nonmetabolized palmitate was absorbed by incubation of
0.1 mL cell supernatant with 0.4 mL charcoal slurry (0.1 g/mL charcoal in 0.02
mol/L Tris-HCl [pH 7.5]) for 30 min. Samples were subjected to centrifuga-
tion (15 min at 16,000 g), 0.2 mL supernatant with tritium-bound water
withdrawn, and radioactivity was determined in a liquid scintillation counter
(LS7000).
Analysis of adipose tissue from humans. All subjects had normal liver,
kidney, and thyroid function; no history of excessive alcohol intake; and no
severe chronic diseases. Biopsies were obtained from abdominal subcutaneous
adipose tissue. Subjects were 78 nondiabetic offspring of patients with type 2
diabetes. Informed consent was obtained from all subjects after the purpose
and potential risks of the study were explained to them. The protocol was
approved by the Ethics Committee of the University of Kuopio and was in
accordance with the Helsinki Declaration. Total RNA from subcutaneous ad-
ipose tissue was isolated using TRIzol reagent (Invitrogen) and an RNeasy Mini
kit(Qiagen)andtranscribedtocDNAusingrandomprimersandahigh-capacity
cDNA archive kit (Applied Biosystems). Quantitative RT-PCRs were performed
in a 7500 Real-Time PCR System (Applied Biosystems) using 6 ng (RNA
equivalents) of cDNA as template, gene-speciﬁc primers and probes (in-
formation on primers and probes available upon request from Applied Bio-
systems). Expression levels were normalized to large ribosomal protein P0
(Hs99999902_ml, Applied Biosystems) using the standard curve method.
Statistics. All values are given as means 6 SE. Student t test was used for
statistical analyses, except in the case of the metabolic OCR and ECAR
analyses, which used two-way ANOVA (mixed design) with Bonferroni post
hoc tests. In the analyses after adenovirus mediated overexpression of FOXC2
in human adipocytes one-way ANOVA were used. For the analysis of gene
expression in human adipose tissue Pearson correlations were calculated.
A P value of less than 0.05 was considered to be signiﬁcant.
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Foxc2 activates mtTFA/Tfam transcription in adipo-
cytes. The ﬁndings that Foxc2 promotes formation of
mitochondrial dense BAT in vivo (13) prompted us to
further investigate the role of Foxc2 in the regulation of
genes of fundamental importance for mitochondrial
function. We made a promoter reporter construct for the
nuclear-encoded mitochondrial transcription factor A
(mtTFA also referred to as Tfam), which plays a crucial
role in mitochondrial transcription and biogenesis (22–25).
FIG. 1. Foxc2 regulates mtTFA. A: 3T3-L1 cells were transiently transfected with a luciferase reporter plasmid harboring an mtTFA promoter and
an increasing amount (0–400 ng) of FOXC2 expression vector. **P = 0.01. B: Real-time PCR analysis of mtTFA mRNA expression in white adipose
tissue (WAT) and brown adipose tissue (BAT) derived from Foxc2 overexpressing mice (gray bars) and WT littermates (black bars). **P = 0.01;
***P = 0.001. C: Cotransfections in 3T3-L1 cells using mtTFA-promoter-luciferase reporter-construct and expression vectors for a selection of
forkhead genes (Foxc2, Foxf2, Foxi1, and FoxO1). **P = 0.01; n =3 .
FIG. 2. MEFs with elevated Foxc2 expression have increased levels of mitochondrial DNA, elongated mitochondria, and induced expression of
genes in the electron transport chain. Mitochondrial area and length measured in 150 view ﬁelds on differentiated MEFs derived from WT and
Foxc2 transgenic mice (A–D) are shown. ***P = 0.001. Representative electron micrographs of differentiated MEFs (A and B) are shown. Real-time
PCR analysis of Cytochrome B and Cyklophilin A genomic DNA (E) and genes in electron transport chain complexes I (Ndufs4), III (Sdha), and IV
(COXII) in differentiated MEFs (F) from Foxc2 transgenic mice (gray bars) and cells from WT littermates (black bars) is shown. *P = 0.05; **P =
0.01; ***P = 0.001; n = 3. Scale bar represents 2 mm( 1mm in magniﬁed view ﬁeld).
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adipocytes FOXC2 signiﬁcantly induced mtTFA/Tfam re-
porter activity approximately fourfold (Fig. 1A). This
ﬁnding was conﬁrmed in mice having increased Foxc2
expression in adipose tissue since the steady state levels
of mtTFA mRNA were elevated (Fig. 1B). Because the
forkhead gene family has many members with similar
DNA-binding domains, we were curious whether the ob-
served mtTFA reporter activation could be extended to
include other forkhead genes or whether it was a feature
of some exclusiveness for Foxc2. Transfections using
3T3-L1 adipocytes demonstrate that although Foxc2,
as expected, induces reporter gene activity ;3.5 times,
no signiﬁcant activation was observed for the forkhead
genes: Foxf2, Foxi1,o rFoxo1 (Fig. 1C). Thus the ability
to induce mtTFA appears to be restricted to Foxc2 and
not a function common to all forkhead genes.
FOXC2 induces adipocyte mitochondriogenesis and
altered mitochondrial structure. To evaluate the bi-
ological consequences of Foxc2 as a regulator of mtTFA
transcription, we derived MEFs from mice transgenic for
an adipose-speciﬁc aP2-Foxc2 transgene and from WT
littermates. If such MEF cells were allowed to differentiate
into adipocytes, transmission electron microscopy re-
vealed that mitochondrial area increased by over twofold
in MEF adipocytes with enhanced Foxc2 levels as com-
pared with WT MEF adipocytes (Fig. 2A–C). Moreover
mitochondrial structural characteristics were affected: MEF
adipocytes with enhanced Foxc2 expression have dis-
tinctly elongated mitochondria (Fig. 2B and D), which is
consistent with mitochondrial fusion. This indicates that in
adipocytes Foxc2 activates mitochondrial DNA synthesis
and transcription as well as biogenesis and fusion. mtDNA
quantiﬁcations performed using a PCR-based method
showed a signiﬁcant increase of mtDNA content in FOXC2
MEF adipocytes as compared with WT MEF adipocytes
(Fig. 2E). To test whether this increase reﬂects a corre-
sponding increase in genes related to mitochondrial activity
we measured mRNA levels for genes encoding components
of respiratory complexes I, III, and IV. Expression of the
nuclear-encoded Ndufs4 (complex I) and Sdha (complex II)
as well as the mitochondrial-encoded COXII (complex IV)
were signiﬁcantly upregulated by ;50% (Fig. 2F).
Surprisingly, in the cell line HEK293 having no endoge-
nous Foxc2 expression we found very similar effects on
mitochondrial morphology when Foxc2 was conditionally
expressed using a Tet-on system (Fig. 3), indicating that
Foxc2 expression is sufﬁcient to stimulate mitochondrial
biogenesis and fusion. Using quantitative PCR we com-
pared steady state mRNA levels in adipocytes having vary-
ing levels of Foxc2 and observed upregulated expression of
Mfn1, Mfn2, and Opa1 in cells with higher levels of Foxc2
expression (Fig. 4A). Mfn1 and Mfn2 facilitate docking of
mitochondria and the fusion of the mitochondrial outer
membrane (26) and Opa1 is required for mitochondrial
fusion and integrity of cristae (27). Interestingly, genes
involved in mitochondrial ﬁssion such as ﬁssion 1 (mito-
chondrial outer membrane) homolog (yeast) (Fis1) and
dynamin 1-like (Drp1) are not regulated in relation to
Foxc2 expression levels (Fig. 4A). We could also show that
the BAT-related genes PR domain containing 16 (prdm16)
and deiodinase, iodothyronine, type II (Dio2) were upre-
gulated in adipocytes with enhanced Foxc2 levels (Fig.
4A). In the MEF cells used, expression levels of uncoupling
protein 1 (ucp1) remain unaffected by increased levels of
Foxc2 (Fig. 4A). Ectopically induced Foxc2 expression in
HEK293 cells displays a close to identical gene expression
pattern as compared with that in adipocytes (Fig. 4B), em-
phasizing an important Foxc2-mediated effect on mito-
chondrial morphology and the expression of genes involved
in mitochondrial fusion and BAT-related metabolism. To
verify these ﬁndings in humans we used real-time PCR to
measure levels of mRNA for FOXC2, MFN1, MFN2, OPA1,
PGC1b, and mtTFA/TFAM in human subcutaneous adi-
pose tissue. We found a signiﬁcant or in some cases near
signiﬁcant positive correlation between FOXC2 levels and
MFN1 (P =0 . 0 2 7 ) ,M F N 2( P =0 . 0 5 8 ) ,O P A 1( P =0 . 0 5 7 ) ,
PGC1b (P = 0.001), and mtTFA/TFAM (P = 0.035)
(Supplementary Table 1). This extends the ﬁndings de-
scribed above in mice and argues in favor of a similar
relationship in humans. We can also demonstrate that
in transfection experiments Foxc2, in a dose-dependent
fashion, transactivates both Mfn1 and Mfn2 promoter re-
porter constructs arguing for, at least in part, a direct ef-
fect of Foxc2 on these target genes (Fig. 4C and D). Using
a more direct approach, we infected human adipocytes
FIG. 3. Ectopic expression of Foxc2 in HEK293 cells induces mito-
chondrial biogenesis and fusion. Representative electron micrographs
of control HEK293 cells (2Tet) (A) and of HEK293 cells with an in-
duced FOXC2 expression (+Tet) (B) are shown. Scale bar represents
2 mm( 1mm in magniﬁed view ﬁeld). Western blot analysis (C)o f
doxycycline-induced Foxc2 expression in HEK293 cells (+Tet) and of
control cells (2Tet) is shown. The upper band represents Foxc2, and
the lower band is an unspeciﬁc band that serves as loading control.
Mitochondrial area (D) and length (E) measured in 150 view ﬁelds
on WT HEK293 cells (black bars) and on HEK293 cells presenting a
doxycycline-dependent overexpression of FOXC2 before (2Tet; gray
bars) and after (+Tet; white bars) doxycycline treatment are shown.
***P = 0.001.
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FOXC2. RNA was prepared from such adipocytes, and
levels of mRNA corresponding to DIO2, PRDM16, MFN1,
MFN2, and mtTFA were determined using real-time PCR.
As can be deduced from Fig. 5, adipocytes overexpressing
FOXC2 have signiﬁcantly upregulated these genes or, in
t h ec a s eo fm t T F A ,t h e r ei sac l e a rt r e n di nt h es a m ed i -
rection. Thus transfection experiments (Fig. 1A and C and
Fig. 4C and D), measurements of expression levels in tissues
and MEF-derived adipocytes (Fig. 1B and Fig. 4A), above
mentioned correlations in human adipocytes (Supplementary
Table 1) as well as the result from human adipocytes trans-
duced by a FOXC2-expressing adenovirus (Fig. 5) support
the view that DIO2, PRDM16, MFN1, MFN2, and mtTFA are
positively regulated by FOXC2.
Enhanced aerobic capacity in adipocytes with enhanced
Foxc2 expression. To test whether these Foxc2-induced
changes in mitochondrial morphology and gene expression
patterns correlate with functional parameters we measured
aerobic (oxygen-dependent metabolism) capacity of MEF
adipocytes. Although there is no difference in oxygen con-
sumption during unstimulated conditions, maximal uncou-
pled oxygen consumption was higher in adipocytes with
enhanced Foxc2 expression, demonstrating a greater max-
imum aerobic capacity compared with WT adipocytes (Fig.
6A). Similar measurements were performed to assess the
anaerobic metabolic capacity; here there were no differences
between the two groups of adipocytes during uncoupling
or basal conditions (Fig. 6B). We can also demonstrate an
increased palmitate oxidation in MEF adipocytes with en-
hanced Foxc2 expression (Fig. 6C). Hence, an enhanced
Foxc2 expression appears to positively regulate total oxi-
dation capacity.
Foxc2 as a regulator of metabolo-regulated adaptive
thermogensis. Because cold exposure is a strong inducer
of facultative thermogenesis via activation of UCP1 in vivo
we decided to study whether Foxc2 responds in a similar
manner. WT C57Bl/6 mice were exposed to 4°C for 16 h, and
subsequently RNA was prepared from BAT and WAT. Using
real-time quantitative PCR methodology an expected in-
crease in ucp1 mRNA was noted (Fig. 7A). Although ucp1 is
induced ;10-fold, Foxc2 is repressed by factors of ;14 and
;3 in BAT and WAT, respectively (Fig. 7B and C). Hence,
even though both cold adaptation and FOXC2 have been
implicated as activators of UCP1 expression, they appear to
act through separate mechanisms. To a large extent cold
induction of ucp1 depends on activation of PGC1a (28) since
deletion of PGC1a dramatically reduces cAMP-induced (29)
and cold-induced (30) ucp1 activation. In this context Foxc2
is differently regulated in terms of its independence of
PGC1a for cAMP-mediated induction (29) and its repression
by cold in both BAT and WAT (Fig. 7B and C).
Because PGC1a and -b have been implicated as master
regulators of mitochondrial biogenesis and respiration
FIG. 4. Foxc2 induces expression of genes involved in mitochondrial fusion. Real-time PCR analysis of Mfn1, Mfn2,a n dOpa1 (genes involved in
mitochondrial fusion) and of Fis1 and Drp1 (genes involved in mitochondrial ﬁssion) and Prdm16, Dio2, and Ucp1 (genes expressed in brown fat)
is shown. A: Expression proﬁle of MEF-derived adipocytes from mice deﬁcient in Foxc2 expression (white bars), WT (black bars), and mice
overexpressing Foxc2 (gray bars). **P = 0.01; ***P = 0.001. B: Gene expression in WT HEK293 cells (black bars), uninduced Tet-Foxc2 HEK293
(gray bars), and induced Tet-Foxc2 HEK293 cells (white bars). **P = 0.01; ***P = 0.001; n = 3. Transient transfections of 3T3-L1 cells with a Foxc2
expression vector together with Mfn1 (C)o rMfn2 (D) promoter reporter constructs show that Foxc2 induce the promoters in a dose-dependent
way. ***P = 0.001; n =3 .
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between Foxc2 and these two loci in terms of regulation in
adipocytes. We used MEF-derived adipocytes with varying
levels of Foxc2: no expression (2/2) WT, and enhanced
Foxc2 expression to score mRNA levels of PGC1a (Fig. 7D).
In response to enhanced levels of Foxc2 there was up-
regulated expression of PGC1a, whereas lack of Foxc2 did
not affect PGC1a expression (Fig. 7D). On the other hand,
levels of PGC1b were repressed to approximately half
of those in WT adipocytes when Foxc2 is absent. PGC1b
expression was not affected by increases in Foxc2 ex-
pression (Fig. 7D). This is compatible with a view that
cellular levels of Foxc2 mRNA inﬂuence the levels of
PGC1a and -b and that Foxc2 indirectly or directly acts
as an upstream regulator of PGC1a. This notion gains
support from the fact that adipocytes lacking PGC1a dy-
namically regulate Foxc2 levels, whereas this is not the
case for several other metabolically important genes, e.g.,
Dio2 (29). Using the same experimental approach, we
measured mtTFA mRNA levels (Fig. 7E) and found a pro-
ﬁle very similar to that of PGC1a (Fig. 7D). Thus, although
both PGC1a and mtTFA levels are upregulated in response
to increased levels of Foxc2, they are not dependent on
Foxc2 for basal WT levels of expression since adipocytes
lacking Foxc2 have no signiﬁcant difference in expression
levels as compared with WT adipocytes (Fig. 7D and E).
DISCUSSION
Foxc2 expression modiﬁes mitochondrial ultrastucture.
Mitochondria in adipocytes with elevated Foxc2 expres-
sion were signiﬁcantly more elongated, and there was
concomitantly enhanced expression of genes known to
regulate mitochondrial fusion, namely Mfn1, Mfn2,a n d
OPA1, whereas genes regulating mitochondrial ﬁssion Fis1
and Drp1 were not regulated (Fig. 4A). Interestingly, these
ﬁndings regarding a positive relation between Foxc2 ex-
pression and that of mtTFA/Tfam, Mfn1, Mfn2, and OPA1
can be replicated in human adipose tissue with signiﬁcant
or near signiﬁcant correlation (Supplementary Table 1),
indicating that the proposed function of Foxc2 most likely
also operates in human adipose tissue. This notion is fur-
ther supported by adenoviral overexpression of FOXC2 in
FIG. 5. Effects of an increased FOXC2 expression in human adipocytes.
Quantitative real-time PCR analyses of the expression levels of DIO2
(A), PRDM16 (B), MFN1 (C), MFN2 (D), and mtTFA (E) in human
adipocytes infected either by a control adenovirus expressing ZS-green
(Ctrl) or by an adenovirus expressing FOXC2 (FOXC2) are shown.
*P = 0.05; **P = 0.01; n =3 .
FIG. 6. Cells overexpressing Foxc2 have increased aerobic capacity and
enhanced levels of palmitate oxidation. A: Oxygen consumption rates in
MEF-derived adipocytes from WT and Foxc2 overexpressing mice. Basal
rates were determined in the absence of uncoupler (black bars),
whereas maximal rates were determined after the addition of un-
coupler (1 mmol/L FCCP; gray bars; n = 4 multiwell plates/genotype).
*P = 0.05; ***P = 0.001. B: Extracellular acidiﬁcation rates, a surrogate
measure of glycolytic activity (see RESEARCH DESIGN AND METHODS), in MEF-
derived adipocytes from WT and Foxc2 overexpressing mice. Basal rates
were determined in the absence of uncoupler (black bars), whereas
maximal rates were determined after the addition of uncoupler
(1 mmol/L FCCP; gray bars; n = 4 multiwell plates/genotype). *P = 0.05;
**P = 0.01. C: Palmitate oxidation was measured in MEF-derived adi-
pocytes from WT (black bars) and FOXC2 overexpressing (gray bars)
mice under basal conditions and in the presence of 100 nmol/L insulin
(inhibitor of fatty acid oxidation) or 1 mmol/L AICAR (activator of
AMP-activated protein kinase [AMPK]). Values are calculated as fold
differences compared with palmitate oxidation under basal conditions
in MEF-derived adipocytes from WT mice (n = six multiwell plates/
genotype). **P = 0.01; ***P = 0.001. As expected, insulin decreased,
whereas AICAR stimulated fatty acid oxidation in a similar manner
both in the adipocytes derived from WT and FOXC2 overexpressing
mice. Oxidation of palmitate was higher in adipocytes with increased
expression of FOXC2 compared with the WT adipocytes under basal
conditions and after treatment with insulin and AMPK activator
AICAR.
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(Fig. 5). The ectopic expression of Foxc2 in cells that
normally do not express Foxc2 was shown to be sufﬁcient
to induce mitochondrial fusion as well as some of the
downstream target genes that are important in adipocytes
during adaptive thermogenesis, e.g., Dio2 and prdm16
(Fig. 4B). As a functional consequence, adipocytes with
enhanced Foxc2 expression have higher aerobic metabolic
capacity and enhanced b-oxidation (Fig. 6). This is in-
teresting since inhibition of ﬁssion and/or activation of
fusion is found to counteract many of the disease pheno-
types related to insulin resistance and diabetes (1,14,32).
Moreover, it has been shown that in WAT of WT mice with
enhanced life span because of caloric restriction there is
an induced expression of PGC1a, mtTFA, Mfn1, and Mfn2
(33), a response very similar to what we demonstrate in
adipocytes with enhanced Foxc2 expression (Figs. 1, 4, 5,
and 7D and E). This emphasizes that many of the signaling
pathways induced during caloric restriction also regulate
energy metabolism (34), which make them interesting as
potential targets for treating metabolic diseases like in-
sulin resistance and diabetes. It also opens the possibility
that even though different in some respects, cellular re-
sponses evoked by caloric restriction to some extent are
similar to those activated by adaptive thermogenesis in re-
sponse to, and as a possible defense against, caloric over-
load. Recently, it was shown that mice lacking Fsp27, a
member of the Cide family of proteins, display an induction
of the BAT compartment together with increased levels of
Foxc2 and increase in mitochondrial size (35).
In contrast with both ucp1 and pgc1a, which are in-
duced by cold (28,36) adipocyte, steady state levels of
Foxc2 mRNA are suppressed by lowered temperature (Fig.
7B and C). Foxc2, therefore, seems to have a distinctly
different role in regulation of mitochondrial function from
that seen in cold-induced adaptive thermogenesis. This
is interesting since UCP1 and PGC1a are indispensable
components of nonshivering or thermoregulatory thermo-
genesis (29,30,37) and that Foxc2 activates PGC1a and
mtTFA (as well as Mfn1, Mfn2, and Opa1). Supported by
the results herein and the fact that Foxc2 is upregulated in
response to a high-calorie diet (13) and to insulin (16),
together with the fact that transgenic overexpression of
Foxc2 in adipose tissue leads to expansion of the BAT
tissue compartment (13), we speculate that Foxc2 plays
a role in regulating a form of adaptive thermogenesis
known as metaboloregulatory thermogenesis (38). This
type of adaptive thermogenesis is distinct from thermo-
regulatory thermogenesis (which is induced by cold and
dependent on cold-induced expression of PGC1a and
ucp1) and is induced in rodents by cafeteria feeding, which
is characterized by expanded BAT depots (39) and in-
creased expression of brown fat-related genes like Dio2
(40). Clearly more experiments are needed to decipher the
exact relationship between metabolo- and thermoreg-
ulated adaptive heat production. However, based on the
FIG. 7. Real-time PCR analysis. Measurements of Ucp1 (A) and Foxc2 (B and C) mRNA in WAT and BAT of WT mice, kept at room temperature
(RT, black bars) or exposed to cold (+4°C for 16 h; gray bars) are shown. **P = 0.01. MEF-derived adipocytes overexpressing Foxc2 have
induced expression of PGC1a and mtTFA. Real-time PCR analysis of PGC1a and PGC1b (D)a n dm t T F A( E) mRNA levels in MEF-derived
adipocytes from mice deﬁcient in Foxc2 expression (white bars), WT (black bars), and mice overexpressing Foxc2 (gray bars) is shown. *P =
0.05; **P = 0.01; n =3 .
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we would like to emphasize the fact that several features
of cold-induced BAT activation such as increased BAT
mass, enhanced mitochondriogensis, and activated an-
giogenesis to support elevated metabolism in active BAT
(41) overlap with Foxc2-induced effects on BAT: in-
creased BAT mass (13), enhanced mitochondriogensis
(this article), and stimulation of angiogenesis (42), a no-
tion that further supports the idea of two modes of BAT
activation—one of cold induction and one of nutrient-
regulated Foxc2 induction.
ACKNOWLEDGMENTS
This work was supported by grants to S.E. from the
Swedish Research Council (Grant K2005-32BI-15324-
01A), EU grants (QLK3-CT-2002-02149 and LSHM-CT-
2003-503041), The Arne and IngaBritt Foundation, The
Söderberg Foundation, and the Swedish Foundation for
Strategic Research through the Center for Cardiovascular
and Metabolic Research. Grants to M.-E.H. supporting this
research include those from the Natural Sciences and En-
gineering Research Council and the Canadian Foundation
for Innovation. E.L.S. is supported by a Canadian Diabetes
Association postdoctoral fellowship.
S.W., F.W., and X.-R.P. are employed by AstraZeneca. No
other potential conﬂicts of interest relevant to this article
were reported.
M.E.L., E.L.S., R.W., M.H., A.G., V.S., Z.A., P.I., S.W., F.W.,
J.F.-R., M.L., and X.-R.P. researched data. M.E.L., E.L.S.,
R.W., M.H., A.G., V.S., Z.A., J.F.-R., T.N., M.-E.H., and S.E.
contributed to discussion. M.E.L., E.L.S., R.W., A.G., V.S.,
J.F.-R., M.-E.H., and S.E. wrote the article. M.E.L., E.L.S,
R.W., M.H., A.G., V.S., Z.A., P.I., S.W., F.W., J.F.-R., M.L.,
T.N., X.-R.P., M.-E.H., and S.E. reviewed and edited the
article.
The authors thank Gunilla Petersson (S.E. laboratory)
and Jian Xuan (M.-E.H. laboratory) for technical assistance.
REFERENCES
1. Civitarese AE, Ravussin E. Mitochondrial energetics and insulin re-
sistance. Endocrinology 2008;149:950–954
2. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P.
Nutrient control of glucose homeostasis through a complex of PGC-1alpha
and SIRT1. Nature 2005;434:113–118
3. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes
involved in oxidative phosphorylation are coordinately downregulated in
human diabetes. Nat Genet 2003;34:267–273
4. Björntorp P, Scherstén T, Fagerberg SE. Respiration and phosphorylation
of mitochondria isolated from the skeletal muscle of diabetic and normal
subjects. Diabetologia 1967;3:346–352
5. Koves TR, Ussher JR, Noland RC, et al. Mitochondrial overload and in-
complete fatty acid oxidation contribute to skeletal muscle insulin re-
sistance. Cell Metab 2008;7:45–56
6. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the
elderly: possible role in insulin resistance. Science 2003;300:1140–1142
7. Simoneau JA, Kelley DE. Altered glycolytic and oxidative capacities of
skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol
1997;83:166–171
8. Kim JK, Michael MD, Previs SF, et al. Redistribution of substrates to adi-
pose tissue promotes obesity in mice with selective insulin resistance in
muscle. J Clin Invest 2000;105:1791–1797
9. Fukuchi K, Tatsumi M, Ishida Y, Oku N, Hatazawa J, Wahl RL. Radio-
nuclide imaging metabolic activity of brown adipose tissue in a patient
with pheochromocytoma. Exp Clin Endocrinol Diabetes 2004;112:601–
603
10. Cypess AM, Lehman S, Williams G, et al. Identiﬁcation and importance
of brown adipose tissue in adult humans. N Engl J Med 2009;360:1509–
1517
11. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-
activated brown adipose tissue in healthy men. N Engl J Med 2009;360:
1500–1508
12. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in
healthy adults. N Engl J Med 2009;360:1518–1525
13. Cederberg A, Grønning LM, Ahrén B, Taskén K, Carlsson P, Enerbäck S.
FOXC2 is a wingedhelix gene that counteracts obesity, hypertriglyceridemia,
and diet-induced insulin resistance. Cell 2001;106:563–573
14. Bach D, Pich S, Soriano FX, et al. Mitofusin-2 determines mitochondrial
network architecture and mitochondrial metabolism. A novel regulatory
mechanism altered in obesity. J Biol Chem 2003;278:17190–17197
15. Lodi R, Tonon C, Valentino ML, et al. Deﬁcit of in vivo mitochondrial ATP
production in OPA1-related dominant optic atrophy. Ann Neurol 2004;56:
719–723
16. Ridderstråle M, Carlsson E, Klannemark M, et al. FOXC2 mRNA expres-
sion and a 59 untranslated region polymorphism of the gene are associated
with insulin resistance. Diabetes 2002;51:3554–3560
17. Winnier GE, Hargett L, Hogan BL. The winged helix transcription factor
MFH1 is required for proliferation and patterning of paraxial mesoderm in
the mouse embryo. Genes Dev 1997;11:926–940
18. Cederberg A, Grände M, Rhedin M, Peng XR, Enerbäck S. In vitro differ-
entiated adipocytes from a Foxc2 reporter knock-in mouse as screening
tool. Transgenic Res 2009;18:889–897
19. Simionescu N, Simionescu M. Galloylglucoses of low molecular weight
as mordant in electron microscopy. II. The moiety and functional
groups possibly involved in the mordanting effect. J Cell Biol 1976;70:622–
633
20. da-Silva WS, Harney JW, Kim BW, et al. The small polyphenolic molecule
kaempferol increases cellular energy expenditure and thyroid hormone
activation. Diabetes 2007;56:767–776
21. Rune A, Salehzadeh F, Szekeres F, Kühn I, Osler ME, Al-Khalili L. Evidence
against a sexual dimorphism in glucose and fatty acid metabolism in
skeletal muscle cultures from age-matched men and post-menopausal
women. Acta Physiol (Oxf) 2009;197:207–215
22. Choi YS, Kim S, Pak YK. Mitochondrial transcription factor A (mtTFA) and
diabetes. Diabetes Res Clin Pract 2001;54(Suppl. 2):S3–S9
23. Ekstrand MI, Falkenberg M, Rantanen A, et al. Mitochondrial transcription
factor A regulates mtDNA copy number in mammals. Hum Mol Genet 2004;
13:935–944
24. Larsson NG, Wang J, Wilhelmsson H, et al. Mitochondrial transcription
factor A is necessary for mtDNA maintenance and embryogenesis in mice.
Nat Genet 1998;18:231–236
25. Virbasius JV, Scarpulla RC. Activation of the human mitochondrial tran-
scription factor A gene by nuclear respiratory factors: a potential regula-
tory link between nuclear and mitochondrial gene expression in organelle
biogenesis. Proc Natl Acad Sci USA 1994;91:1309–1313
26. Koshiba T, Detmer SA, Kaiser JT, Chen H, McCaffery JM, Chan DC.
Structural basis of mitochondrial tethering by mitofusin complexes. Sci-
ence 2004;305:858–862
27. Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mito-
chondrial inner membrane structure and integrity, leading to cytochrome c
release and apoptosis. J Biol Chem 2003;278:7743–7746
28. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-
inducible coactivator of nuclear receptors linked to adaptive thermo-
genesis. Cell 1998;92:829–839
29. Uldry M, Yang W, St-Pierre J, Lin J, Seale P, Spiegelman BM. Comple-
mentary action of the PGC-1 coactivators in mitochondrial biogenesis and
brown fat differentiation. Cell Metab 2006;3:333–341
30. Lin J, Wu PH, TarrPT, et al. Defects in adaptive energy metabolism
with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004;119:
121–135
31. Rohas LM, St-Pierre J, Uldry M, Jäger S, Handschin C, Spiegelman BM. A
fundamental system of cellular energy homeostasis regulated by PGC-1
alpha. Proc Natl Acad Sci USA 2007;104:7933–7938
32. Yu T, Robotham JL, Yoon Y. Increased production of reactive oxy-
gen species in hyperglycemic conditions requires dynamic change of
mitochondrial morphology. Proc Natl Acad Sci USA 2006;103:2653–
2658
33. Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mito-
chondrial biogenesis by inducing the expression of eNOS. Science 2005;
310:314–317
34. Boily G, Seifert EL, Bevilacqua L, et al. SirT1 regulates energy metabolism
and response to caloric restriction in mice. PLoS One 2008;3:e1759
35. Toh SY, Gong J, Du G, et al. Up-regulation of mitochondrial activity and
acquirement of brown adipose tissue-like property in the white adipose
tissue of fsp27 deﬁcient mice. PLoS ONE 2008;3:e2890
Foxc2 REGULATES MITOCHONDRIAL FUNCTION
434 DIABETES, VOL. 60, FEBRUARY 2011 diabetes.diabetesjournals.org36. Milner RE, Trayhurn P. Cold-induced changes in uncoupling protein and GDP
binding sites in brown fat of ob/ob mice. Am J Physiol 1989;257:R292–R299
37. Enerbäck S, Jacobsson A, Simpson EM, et al. Mice lacking mitochondrial
uncoupling protein are cold-sensitive but not obese. Nature 1997;387:90–94
38. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological
signiﬁcance. Physiol Rev 2004;84:277–359
39. Rothwell NJ, Stock MJ. A role for brown adipose tissue in diet-induced
thermogenesis. Nature 1979;281:31–35
40. Glick Z, Wu SY, Lupien J, Reggio R, Bray GA, Fisher DA. Meal-induced
brown fat thermogenesis and thyroid hormone metabolism in rats. Am J
Physiol 1985;249:E519–E524
41. Xue Y, Petrovic N, Cao R, et al. Hypoxia-independent angiogenesis in
adipose tissues during cold acclimation. Cell Metab 2009;9:99–109
42. Xue Y, Cao R, Nilsson D, et al. FOXC2 controls Ang-2 expression and
modulates angiogenesis, vascular patterning, remodeling, and functions in
adipose tissue. Proc Natl Acad Sci USA 2008;105:10167–10172
M.E. LIDELL AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, FEBRUARY 2011 435